Charles River Laboratories International (CRL) Change in Account Payables (2009 - 2025)

Charles River Laboratories International's Change in Account Payables history runs 17 years deep, the most recent figure standing at -$37.9 million for Q4 2025.

• In Q4 2025, Change in Account Payables fell 427.84% year-over-year to -$37.9 million; the TTM figure through Dec 2025 stood at $2.9 million (up 120.1% YoY), while the FY2025 annual figure was $2.9 million, up 120.1% from the prior year.
• Change in Account Payables was -$37.9 million for Q4 2025 at Charles River Laboratories International, down from $24.5 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $40.9 million in Q1 2022 to a low of -$41.3 million in Q2 2023.
• Historically, Change in Account Payables has averaged $521000.0 across 5 years, with a median of -$1.1 million in 2023.
• Biggest YoY gain for Change in Account Payables was 3818.66% in 2025; the steepest drop was 528.03% in 2025.
• A 5-year view of Change in Account Payables shows it stood at $33.5 million in 2021, then plunged by 125.79% to -$8.6 million in 2022, then surged by 170.72% to $6.1 million in 2023, then sank by 217.56% to -$7.2 million in 2024, then sank by 427.84% to -$37.9 million in 2025.
• The last three Change in Account Payables figures came in at -$37.9 million (Q4 2025), $24.5 million (Q3 2025), and -$9.0 million (Q2 2025), per Business Quant data.